戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 cute hyperkalemia with the administration of succinylcholine.
2 nst the risk of side effects associated with succinylcholine.
3 ical evaluation as a possible alternative to succinylcholine.
4  a blunted response to a spindle sensitizer, succinylcholine.
5  changes were abolished after paralysis with succinylcholine.
6 sal muscle fibres, derived from testing with succinylcholine.
7 increased sensitivity to the muscle relaxant succinylcholine.
8  a blunted response to a spindle sensitizer, succinylcholine.
9 /kg vs 0.87 [0.78-1.00] mg/kg; P = .007) and succinylcholine (0.33 [0.27-0.39] mg/kg vs 0.53 [0.45-0.
10  trial comparing rocuronium (1.2 mg/kg) with succinylcholine (1 mg/kg) for rapid sequence intubation
11  situation, laryngospasm can be treated with succinylcholine administration by intramuscular, intraos
12       The depolarizing neuromuscular blocker succinylcholine also stabilizes a desensitized channel b
13 a pharmacodynamic profile similar to that of succinylcholine) and AV002 (with an intermediate duratio
14 terase through genotyping patients with post-succinylcholine apnea.
15                               Rocuronium and succinylcholine are often used for rapid sequence intuba
16                                              Succinylcholine arguably remains the preferred neuromusc
17 cal indication treated with methohexital and succinylcholine between March 16, 2017, and March 15, 20
18                  Upon injection of 820 pL of succinylcholine chloride in a 10-microm capillary, a con
19                 Two-microliter injections of succinylcholine chloride in a 5-cm x 1-mm C-18 column wi
20                       Static measurements of succinylcholine chloride in water have shown a detection
21 parations of citrate and nitrate, as well as succinylcholine chloride with sodium salicylate using ac
22 roduces a profound increase in activation by succinylcholine compared with either wild-type alpha7 or
23 emergency setting, rocuronium, compared with succinylcholine, failed to demonstrate noninferiority wi
24 ocuronium group vs 489 of 616 (79.4%) in the succinylcholine group, with a between-group difference o
25 otension (62 of 616 patients [10.1%]) in the succinylcholine group.
26 red by inhalational volatile anesthetics and succinylcholine in genetically susceptible patients.
27 tics and/or the depolarizing muscle relaxant succinylcholine in malignant hyperthermia-susceptible in
28 anophosphate toxicity, as drugs to alleviate succinylcholine-induced apnea, and as detoxification age
29 t was given 14 mg of etomidate and 100 mg of succinylcholine intravenously.
30  be added to the list of conditions in which succinylcholine is contraindicated.
31 ation facilitated by rocuronium (n = 624) or succinylcholine (n = 624).
32                          The side effects of succinylcholine occur in relatively predictable circumst
33 ensitivity to vibration and by the effect of succinylcholine on their response to ramp-and-hold muscl
34 o receive neuromuscular blockers (1 mg/kg of succinylcholine or rocuronium; n = 575) or remifentanil
35 to passive muscle stretch and the effects of succinylcholine (SCh) and by their sensitivity to vibrat
36                   The regimen of thiopental, succinylcholine (SCh) and unsupplemented nitrous oxide/o
37           Each afferent was characterised by succinylcholine testing with regard to its intrafusal fi
38                                              Succinylcholine use has been associated with several adv
39  of muscle spindles to tendon stretch and to succinylcholine, whereas the high dose (5 microg kg(-1))
40 f fatal hyperkalemia after administration of succinylcholine, with a mechanism similar to that report